Active Ingredient: PERAMIVIR
Proprietary Name: RAPIVAB
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 200MG/20ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N206426
Product Number: 001
Approval Date: Dec 19, 2014
Applicant Holder Full Name: BIOCRYST PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
